Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00456716 · ClinicalTrials.gov registry record · Phase 2
Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma
A Phase 2 study, sponsored by Swedish Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00456716 is a Phase 2 study that has completed, run by Swedish Medical Center. The registered enrollment target is 5 participants.
The verdict
NCT00456716, a Phase 2 study, has completed, sponsored by Swedish Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
Open label study of sorafenib
Interventions
- DRUG sorafenib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00456716
The ClinicalTrials.gov registry entry for NCT00456716 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Swedish Medical Center, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sorafenib is the first listed.
NCT00456716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00456716 about?
NCT00456716 is a clinical study titled "Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma". Open label study of sorafenib
What is the current status of trial NCT00456716?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2007-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00456716?
The interventions under investigation include: sorafenib (DRUG).
Who is sponsoring clinical trial NCT00456716?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.